- Home
- ALDX vs RXT Comparison
ALDX vs RXT Comparison
Compare ALDX & RXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- RXT
- Stock Information
- Founded
- ALDX 2004
- RXT 1998
- Country
- ALDX United States
- RXT United States
- Employees
- ALDX N/A
- RXT N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- RXT EDP Services
- Sector
- ALDX Health Care
- RXT Technology
- Exchange
- ALDX Nasdaq
- RXT Nasdaq
- Market Cap
- ALDX 270.7M
- RXT 314.5M
- IPO Year
- ALDX 2014
- RXT 2020
- Fundamental
- Price
- ALDX $4.81
- RXT $1.18
- Analyst Decision
- ALDX Strong Buy
- RXT Hold
- Analyst Count
- ALDX 2
- RXT 4
- Target Price
- ALDX $9.50
- RXT $1.63
- AVG Volume (30 Days)
- ALDX 1.2M
- RXT 928.5K
- Earning Date
- ALDX 08-12-2025
- RXT 08-07-2025
- Dividend Yield
- ALDX N/A
- RXT N/A
- EPS Growth
- ALDX N/A
- RXT N/A
- EPS
- ALDX N/A
- RXT N/A
- Revenue
- ALDX N/A
- RXT $2,711,700,000.00
- Revenue This Year
- ALDX N/A
- RXT N/A
- Revenue Next Year
- ALDX $29.89
- RXT $1.48
- P/E Ratio
- ALDX N/A
- RXT N/A
- Revenue Growth
- ALDX N/A
- RXT N/A
- 52 Week Low
- ALDX $1.14
- RXT $1.00
- 52 Week High
- ALDX $7.20
- RXT $3.41
- Technical
- Relative Strength Index (RSI)
- ALDX 53.97
- RXT 37.49
- Support Level
- ALDX $5.21
- RXT $1.28
- Resistance Level
- ALDX $5.35
- RXT $1.51
- Average True Range (ATR)
- ALDX 0.33
- RXT 0.12
- MACD
- ALDX -0.12
- RXT -0.03
- Stochastic Oscillator
- ALDX 40.70
- RXT 6.82
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
About RXT Rackspace Technology Inc.
Rackspace Technology Inc is an end-to-end, hybrid, multi cloud technology services company. It designs, builds and operates its customers' cloud environments across all technology platforms, irrespective of technology stack or deployment model. The company's solutions include Application Services; Data; Colocation; Cloud; Managed Hosting; Professional Services; and Security & Compliance. It operates in segments namely, Private Cloud, and Public Cloud. It generates revenue through the sale of consumption-based contracts for its service offerings and from the sale of professional services related to designing and building custom solutions.